Costa Rica vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB
Costa Rica
100.0%
in 2019
South-East Asia (WHO region)
77.0%
in 2022
Costa Rica rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate for patients treated for MDR-TB over time
- Costa Rica
- South-East Asia (WHO region)
How they compare
Costa Rica currently reports 100.0% against 77.0% in South-East Asia (WHO region), a difference of 23.0%.
That makes Costa Rica's figure about 1.3 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 6 shared years of data; in 2009 it was Costa Rica ahead.
Costa Rica ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
Costa Rica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 54.0% | 46.0% | Costa Rica |
| 2010s | 81.6% | 54.4% | 27.2% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Costa Rica or South-East Asia (WHO region)?
- Costa Rica, at 100.0% against 77.0% in South-East Asia (WHO region) as of 2019.
- What is the difference in treatment success rate for patients treated for mdr-tb between Costa Rica and South-East Asia (WHO region)?
- 23.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and South-East Asia (WHO region)?
- 6 years are reported by both, from 2009 to 2019.
- How do Costa Rica and South-East Asia (WHO region) rank globally for treatment success rate for patients treated for mdr-tb?
- Costa Rica ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.